Remimazolam besylate versus propofol for deep sedation in critically ill patients: a randomized pilot study.

"Declarations Ethics approval and consent to participateThe study was conducted in accordance with the Declaration of Helsinki and national and institutional standards. The study was approved by the Ethics Committee of Wuhan Union Hospital (2022-0539-01). Written informed consent was obtained from legally authorized representatives. Consent for publicationNot applicable. Competing interestsThe authors declare that they have no competing interests. Competing interests The authors declare that they have no competing interests."

"Funding No funding."

"This single-center, prospective, randomized, controlled study was conducted from September 2022 to May 2023 in Union Hospital, Wuhan, China. The Ethics Committee of our hospital approved this study (2022-0539-01). Written informed consent was obtained from legally representatives. The study was registered (ClinicalTrials.gov, NCT05539521)."